Supernova 2

Supernova Invest, established in 1999, is a Paris-based private equity and venture capital firm with additional offices in Grenoble. It manages a €800m fund, Supernova 2, founded in 2017. The firm specializes in early-stage investments, focusing on deep technology companies across sectors such as healthcare, industry 4.0, energy & environment, and digital technologies. It provides patient capital and expertise to support high-growth startups, with a track record of successful exits through IPOs and M&As. Supernova Invest partners with CEA Investissement to offer startups access to the CEA network and services.

Cécile Benet

Investment Director

Lucille Benoît

Analyst

Alexandre Biau

Investment Director

Alexandre Biau

Investment Director

Damien Bretegnier

Investment Director

Pascal-André Chenal

Investment Manager

Pascal-andré Chenal

Investment Director

Alexandre Cordier

Analyst

Arthur Falinower

Analyst

Marine Glon

Investment Director

Celia Hart Ph.D

General Partner

Claude-Sebastien Lerbourg

Investment Director

Claude-Sebastien Lerbourg

Investment Director

Etienne Moreau

Partner

Arthur Puig

Associate

Régis Saleur

Managing Partner

Romain Sautrau

Investment Director

Remi Spagnol

Investment Director

Pierre-Emmanuel Struyven

Managing Partner

Michael Thomas

Investment Director

Nicolas Topuz

Analyst

Gregoire Viot

CFO

Past deals in Laser

mirSense

Series A in 2025
mirSense develops Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules for gas analysis. Its products enable industries and defense sectors to monitor and control gas emissions, improve air quality, and enhance medical treatment accuracy.

SCINTIL Photonics

Venture Round in 2022
SCINTIL Photonics is a fabless company focused on silicon photonics, developing silicon photonic integrated circuits. It combines silicon and indium phosphide materials using wafer-scale bonding to create fully integrated photonic circuits, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors, designed for high-speed data communication. The company relies on commercial silicon foundry processes and offers co-packaged and pluggable formats to enhance AI data center bandwidth and performance. Headquartered in Grenoble, France.

Cailabs

Series B in 2019
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

SCINTIL Photonics

Seed Round in 2019
SCINTIL Photonics is a fabless company focused on silicon photonics, developing silicon photonic integrated circuits. It combines silicon and indium phosphide materials using wafer-scale bonding to create fully integrated photonic circuits, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors, designed for high-speed data communication. The company relies on commercial silicon foundry processes and offers co-packaged and pluggable formats to enhance AI data center bandwidth and performance. Headquartered in Grenoble, France.

mirSense

Seed Round in 2018
mirSense develops Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules for gas analysis. Its products enable industries and defense sectors to monitor and control gas emissions, improve air quality, and enhance medical treatment accuracy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.